LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma
NCT00412997
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Cutaneous T-Cell Lymphoma
Interventions
DRUG:
LBH589
Sponsor
Novartis